Agenda

Time

Topic

Speaker

Interprofessional Session

8:00 – 9:00 AM

Registration, Breakfast & Exhibits

9:00 – 9:15 AM

Welcome, Introductions and Presession ARS

9:15 – 10:35 AM

Moderator: Andrew Evens, DO, MBA, MSc

Mini Symposium on HRQOL and Symptom Management

9:15 AM

Nursing Perspective on Managing Neurotoxicity –
What Tools Do We Have?

Tara McCabe, APN-BC, AOCNP

9:35 AM

Strategies for Incorporating PROs into Clinical Trials

Gaurav Goyal, MD

9:55 AM

Addressing HRQoL and Symptom Management in Lymphoma

Priyanka Pophali, MD, MBBS

10:15 AM

Panel Discussion Q&A, and Postsession ARS

10:35 – 10:55 AM

Break & Exhibits

10:55 AM – 12:00 PM

Moderator: Sonali Smith, MD, FASCO

Mini Symposium on Novel Therapies in Lymphoma

10:55 AM

Presession ARS

11:00 AM

Novel Classes of Targeted Agents

Kaitlin Kelly, PharmD, BCOP

11:20 AM

Novel T-Cell Engaging Therapy Approaches –
How Close Are These to Prime Time?

Nirav N. Shah, MD, MSHP

11:40 AM

Panel Discussion Q&A, and Postsession ARS

12:00 – 1:00 PM

Lunch & Exhibits

General Session

1:00 – 1:05 PM

Welcome and Introductions

1:05 – 2:20 PM

Moderator: Neha Mehta-Shah, MD, MSCI

Mini Symposium on Diagnostics in Lymphoma

1:05 PM

Presession ARS

1:10 PM

Baseline Genomic Testing in Lymphoma: Are We There Yet?

Sandeep Dave, MD

1:30 PM

Should Next Generation Hematopathology Influence the Standard of Care in Lymphoma?

Ahmet Dogan, MD, PhD

1:50 PM

Applying Genomic Testing from Bench to Bedside: A Case-Based Discussion

Sandeep Dave, MD,
Ahmet Dogan,
Justin Kline, MD and
Neval Ozkaya, MD

2:10 PM

Audience Q&A, and Postsession ARS

2:20 – 2:50 PM

Break & Exhibits

2:50 – 4.00 PM

Moderator: Sonali Smith, MD, FASCO

Challenging Clinical Scenarios in CNS Lymphoma

Lakshmi Nayak, MD,
Alexandra Rojek, MD and
Hunter Cochran, MD

4:00 – 5:20 PM

Moderator: Timothy Fenske, MD, MS

Mini Symposium on DLBCL

4:00 PM

Presession ARS

4:05 PM

Frontline Treatment Options in Newly Diagnosed DLBCL

Sumana Devata, MD

4:25 PM

Relapsed/Refractory DLBCL: The Role of CAR T-Cells vs
Bispecifics in First Relapse

Peter Riedell, MD

4:45 PM

Frail/Older Patients With DLBCL: A Persistent Challenge

Pallawi Torka, MD

5:05 PM

Panel Discussion, Q&A, and Postsession ARS

5:20 PM

Day 1 Wrap Up and Summary

5:20 – 6:20 PM

Welcome & Poster Reception with Exhibitors

Time

Topic

Speaker

General Session

7:00 – 8:00 AM

Registration, Breakfast & Exhibits

8:00 – 8:05 AM

Welcome and Introductions

8:05 – 8:25 AM

Moderator: Andrew Evens, DO, MBA, MSc

Globalizing Lymphoma Research: Challenges and Opportunities

Luis Malpica Castillo, MD

8:25 – 8:30 AM

Q&A

8:30 – 9:55 AM

Moderator: Neha Mehta-Shah, MD, MSCI

Mini Symposium on Mantle Cell Lymphoma

8:30 AM

Presession ARS

8:35 AM

What Is the Current Role of BTK Inhibitors in Frontline Therapy for MCL?

Tycel Phillips, MD

8:55 AM

Challenges in Treating Patients with TP53-Mutated MCL

Lori Leslie, MD

9:15 AM

Relapsed/Refractory MCL: What is the Role of Cellular Therapy and Transplant?

Timothy Fenske, MD, MS

9:35 AM

Panel Discussion, Q&A, and Postsession ARS

9:50 AM

Moderator: Sonali Smith, MD, FASCO

How I Approach Treatment-Naïve CLL/SLL

Deborah Stephens, DO

10:10 – 10:30 AM

Break & Exhibits

10:30 – 12:15 PM

Moderator: Jane N. Winter, MD

Duels in Lymphoma

What Is the Optimal Approach to Treating Newly Diagnosed Hodgkin Lymphoma?

10:30 AM

Nivo-AVD

Andrew M. Evens, DO, MBA, MSc

10:45 AM

A-AVD

Adam DuVall, MD, MPH

11:00 AM

“European” Regimens

Leo Gordon, MD

11:15 AM

Hodgkin Lymphoma Rebuttal: How Does the Selection of 1L Therapy Impact Sequencing of Subsequent Agents?

Pamela Allen, MD

Selection of Therapy for Relapsed Follicular Lymphoma

11:30 AM

CAR T-Cells

Nirav Shah, MD, MSHP

11:45 AM

Bispecifics

Reem Karmali, MD

12:00 PM

Non-T-Cell Engaging Option

Sonali Smith, MD, FASCO

12:15 – 1:25 PM

Lunch, Exhibits, and Meet the Professor Session

1:25 – 2:25 PM

Moderator: Sonali Smith, MD, FASCO

Keynote Presentation: 

Prioritizing Clinical Research in a Clinical Practice

Nancy Bartlett, MD

2:25 – 3:00 PM

Moderators: Timothy Fenske, MD, MS
and Andrew Evens, DO, MBA, MSc

Case-Based Panel Discussion

Symposium Co-Chairs
and Advisory Committee

3:00 PM

Adjourn